Literature DB >> 19564592

Re: CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy.

Y Fichou, E Bieth, N Bahi-Buisson, J Nectoux, B Girard, J Chelly, Y Chaix, T Bienvenu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564592     DOI: 10.1212/01.wnl.0000349658.05677.d7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

1.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

Review 2.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

Review 3.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

4.  Cell cloning-based transcriptome analysis in cyclin-dependent kinase-like 5 mutation patients with severe epileptic encephalopathy.

Authors:  Juliette Nectoux; Yann Fichou; Nicolas Cagnard; Nadia Bahi-Buisson; Patrick Nusbaum; Franck Letourneur; Jamel Chelly; Thierry Bienvenu
Journal:  J Mol Med (Berl)       Date:  2010-11-24       Impact factor: 4.599

5.  CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-09-13

6.  CDKL5 and ARX mutations in males with early-onset epilepsy.

Authors:  Ghayda M Mirzaa; Alex R Paciorkowski; Eric D Marsh; Elizabeth M Berry-Kravis; Livija Medne; Asem Alkhateeb; Art Grix; Elaine C Wirrell; Berkley R Powell; Katherine C Nickels; Barbara Burton; Andrea Paras; Katherine Kim; Wendy Chung; William B Dobyns; Soma Das
Journal:  Pediatr Neurol       Date:  2013-05       Impact factor: 3.372

7.  There is variability in the attainment of developmental milestones in the CDKL5 disorder.

Authors:  Stephanie Fehr; Helen Leonard; Gladys Ho; Simon Williams; Nick de Klerk; David Forbes; John Christodoulou; Jenny Downs
Journal:  J Neurodev Disord       Date:  2015-01-05       Impact factor: 4.025

8.  Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.

Authors:  Ying Zhao; Xiaoying Zhang; Xinhua Bao; Qingping Zhang; Jingjing Zhang; Guangna Cao; Jie Zhang; Jiarui Li; Liping Wei; Hong Pan; Xiru Wu
Journal:  BMC Med Genet       Date:  2014-02-25       Impact factor: 2.103

Review 9.  Recent advances in understanding synaptic abnormalities in Rett syndrome.

Authors:  Michael Johnston; Mary E Blue; Sakkubai Naidu
Journal:  F1000Res       Date:  2015-12-22

10.  Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase.

Authors:  Ivan M Muñoz; Michael E Morgan; Julien Peltier; Florian Weiland; Mateusz Gregorczyk; Fiona Cm Brown; Thomas Macartney; Rachel Toth; Matthias Trost; John Rouse
Journal:  EMBO J       Date:  2018-09-28       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.